These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39091353)

  • 41. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
    Perera D; Stables R; Thomas M; Booth J; Pitt M; Blackman D; de Belder A; Redwood S;
    JAMA; 2010 Aug; 304(8):867-74. PubMed ID: 20736470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary artery bypass vs percutaneous coronary intervention in under 50s.
    Shafi AMA; Dhanji AAA; Habib AM; Kennon SRO; Awad WI
    J Card Surg; 2020 Feb; 35(2):320-327. PubMed ID: 31803987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
    Feng WH; Chang YC; Lin YH; Chen HL; Chang HM; Chu CS
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of platelet reactivity on clinical events in patients using bivalirudin in selective percutaneous coronary intervention].
    Li JW; Yuan DS; Su SS; Wang ZF; Liu HW; Xu B; Qiao SB; Yang YJ; Gao RL; Yuan JQ; Zhao XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Aug; 49(8):783-789. PubMed ID: 34404187
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
    Puurunen M; Kiviniemi T; Nammas W; Schlitt A; Rubboli A; Nyman K; Karjalainen P; Kirchhof P; Lip GY; Airaksinen JK
    BMJ Open; 2014 May; 4(5):e004700. PubMed ID: 24823675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical characteristics and prognosis between male and female patients with premature coronary artery disease after intervention].
    Tang XF; Song Y; Xu JJ; Wang HH; Jiang L; Jiang P; Yao Y; Zhao XY; Gao Z; Yang YJ; Qiao SB; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):798-805. PubMed ID: 31648462
    [No Abstract]   [Full Text] [Related]  

  • 47. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
    Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
    J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study.
    Shavelle DM; Kirtane AJ; Schreiber TL; Kapasi NK; O'Neill WW; Moses JW; Popma J; Matthews RV
    J Invasive Cardiol; 2016 May; 28(5):187-92. PubMed ID: 26887029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention.
    McKechnie RS; Smith D; Montoye C; Kline-Rogers E; O'Donnell MJ; DeFranco AC; Meengs WL; McNamara R; McGinnity JG; Patel K; Share D; Riba A; Khanal S; Moscucci M;
    Circulation; 2004 Jul; 110(3):271-7. PubMed ID: 15226214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic implications of chronic kidney disease and anemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Takeuchi M; Dohi T; Takahashi N; Endo H; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
    Heart Vessels; 2021 Aug; 36(8):1117-1124. PubMed ID: 33606067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anemia as an independent predictor of poor long-term outcomes after percutaneous coronary intervention].
    Liu XM; Kang JP; Lü Q; Liu XH; Wu XS; Ma CS
    Zhonghua Nei Ke Za Zhi; 2008 Feb; 47(2):114-6. PubMed ID: 18683796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.
    Bertrand OF; Larose E; Rodés-Cabau J; Rinfret S; Déry JP; Bagur R; Gleeton O; Nguyen CM; Proulx G; De Larochellière R; Poirier P; Costerousse O; Roy L
    Am J Cardiol; 2010 Jul; 106(2):155-61. PubMed ID: 20598996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events, and Bleeding in Stable Coronary Artery Disease.
    Kalra PR; Greenlaw N; Ferrari R; Ford I; Tardif JC; Tendera M; Reid CM; Danchin N; Stepinska J; Steg PG; Fox KM;
    Am J Med; 2017 Jun; 130(6):720-730. PubMed ID: 28109968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC).
    Ambulgekar NV; Grey SF; Rosman HS; Othman H; Davis TP; Nypaver TJ; Schreiber T; Yamasaki H; Lalonde TA; Henke PK; Gurm HS; Mehta RH; Grossman PM;
    J Invasive Cardiol; 2018 Jan; 30(1):35-42. PubMed ID: 29289948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Javaid AI; Michalek JE; Gruslova AB; Hoskins SA; Ahsan CH; Feldman MD
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):30-41. PubMed ID: 37997292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
    Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlled.
    Iannaccone M; Barbero U; Franchin L; Montabone A; De Filippo O; D'ascenzo F; Boccuzzi G; Panoulas V; Hill J; Brilakis ES; Chieffo A
    Int J Cardiol; 2024 Feb; 396():131428. PubMed ID: 37820779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.